Commonwealth Equity Services
PCRX icon

Commonwealth Equity Services’s Pacira BioSciences PCRX Stock Holding History

Commonwealth Equity Services’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,793
Closed -$213K – 3767
2022
Q1 		$213K Sell
2,793
-2,261
-45% -$151K ﹤0.01% 3279
2021
Q4 		$304K Buy
+5,054
New +$279K ﹤0.01% 2960
2021
Q2 		– Sell
-3,229
Closed -$226K – 3560
2021
Q1 		$226K Sell
3,229
-150
-4% -$10.7K ﹤0.01% 3030
2020
Q4 		$202K Buy
+3,379
New +$198K ﹤0.01% 2916
2016
Q1 		– Sell
-3,223
Closed -$247K – 2250
2015
Q4 		$247K Buy
+3,223
New +$183K ﹤0.01% 1742
2015
Q3 		– Sell
-3,640
Closed -$257K – 2205
2015
Q2 		$257K Buy
3,640
+956
+36% +$75.3K ﹤0.01% 1744
2015
Q1 		$238K Buy
2,684
+245
+10% +$24.9K ﹤0.01% 1785
2014
Q4 		$216K Hold
2,439
– – ﹤0.01% 1798
2014
Q3 		$236K Buy
2,439
+9
+0.4% +$876 ﹤0.01% 1721
2014
Q2 		$223K Buy
+2,430
New +$185K ﹤0.01% 1751

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return